MS Contin 60 MG Extended Release Oral Tablet
- RxCUI
- 894813
- RxNorm name
- MS Contin 60 MG Extended Release Oral Tablet
- Display name
- MS Contin 60 MG Extended Release Oral Tablet
- Full name
- MS Contin 60 MG Extended Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MS Contin | MORPHINE SULFATE | Rhodes Pharmaceuticals LLC | c354b3bf-86c0-4bb8-8b1f-be2164942698 | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | 894813 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c354b3bf-86c0-4bb8-8b1f-be2164942698 | MS Contin 60 MG Extended Release Oral Tablet [PSN] · morphine sulfate 60 MG Extended Release Oral Tablet [MS Contin] [SBD] · MS 60 MG Extended Release Oral Tablet [MS Contin] [SY] · MS Contin 60 MG Extended Release Oral Tablet [SY] | 4 | 16 | These highlights do not include all the information needed to use MS CONTIN ® safely and effectively. See full prescribing information for MS CONTIN. MS CONTIN ® (morphine sulfate extended-release tablets), for oral use CII Initial U.S. Approval: 1941 | 20260504 |
| 989a17e2-b7fd-478c-a584-327d368247ce | MS Contin 60 MG Extended Release Oral Tablet [PSN] · morphine sulfate 60 MG Extended Release Oral Tablet [MS Contin] [SBD] · MS 60 MG Extended Release Oral Tablet [MS Contin] [SY] · MS Contin 60 MG Extended Release Oral Tablet [SY] | 4 | 1 | MS CONTIN® (morphine sulfate controlled-release) Tablets CII 15 mg 30 mg 60 mg 100 mg * 200 mg * | 20100709 |